The FDA reviewed specific genetic engineering products and published views on the issues surrounding them.
1 report, 1 independent
Updated Jun 16
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
The FDA reviewed specific genetic engineering products and published views on the issues surrounding them.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
Related events
- FDA and state authorities are investigating product manufacturers in Utah.
- FDA and Pfizer are seeking regulatory approval for their products.
- A network focused on cell and gene therapies is expanding to include sites in Northern California, involving the CA Institute for Regenerative Medicine and the FDA.
- Policymakers are considering ways to influence the drug market, including potential changes to patent rights and the FDA approval process.